Comparing Semaglutide vs Tenuate Dospan
| Semaglutide | Tenuate Dospan (diethylpropion) |
|
|---|
| Semaglutide | Tenuate Dospan (diethylpropion) |
|
|---|---|---|
|
Prescription only
Semaglutide (Ozempic, Rybelsus) lowers blood sugar levels by mimicking the effects of GLP-1, a naturally occurring hormone that stimulates insulin secretion and lowers glucagon secretion from the... View more |
Prescription only
Prescribed for Weight Loss (Obesity/Overweight). Tenuate Dospan may also be used for purposes not listed in this medication guide. |
Related suggestions Weight Loss (Obesity/Overweight)
Popular comparisons
|
| More about Semaglutide | More about Tenuate Dospan (diethylpropion) | |
| Ratings & Reviews | ||
|
Semaglutide has an average rating of 6.9 out of 10 from a total of 2638 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 20% reported a negative effect. |
Tenuate Dospan has an average rating of 7.9 out of 10 from a total of 14 ratings on Drugs.com. 79% of reviewers reported a positive effect, while 14% reported a negative effect. |
|
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||
View all Semaglutide side effects |
View all Tenuate Dospan side effects |
|
| Drug Class | ||
| Generic Availability | ||
|
N/A |
Lower cost generic approved | |
| Pricing and Coupons * Prices are without insurance | ||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
| Dosage Forms | ||
|
N/A |
N/A |
|
| Brand Names | ||
| Ozempic, Rybelsus, Wegovy |
N/A |
|
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||
|
168 hours |
6 hours |
|
| CSA Schedule 1 View glossary of CSA terms | ||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
|
| Pregnancy Category | ||
|
Summary unavailable. See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
|
| Drug Interactions | ||
|
A total of 273 drugs are known to interact with Semaglutide:
|
A total of 174 drugs are known to interact with Tenuate Dospan:
|
|
| Alcohol/Food/Lifestyle Interactions | ||
|
||
| Disease Interactions | ||
| First Approval Date | ||
|
December 05, 2017 |
November 17, 1960 |
|
| WADA Class View classifications | ||
|
N/A |
N/A |
|
| More Information | ||
| Patient Resources | ||
| Professional Resources | ||
|
N/A |
||
| Related Treatment Guide | ||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Repatha
Repatha is used to lower high cholesterol alongside dietary changes and to reduce the risk of major ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Mounjaro
Mounjaro is used to treat type 2 diabetes in adults. It is a subcutaneous injection that can be ...
Jardiance
Jardiance (empagliflozin) is used to treat type 2 diabetes, chronic kidney disease and reduce the ...
Farxiga
Farxiga (dapagliflozin) is an oral prescription medication that may be given to certain adults with ...
Lasix
Lasix is a loop diuretic used to treat fluid retention from heart, liver, or kidney conditions, and ...
Xarelto
Xarelto (rivaroxaban) is a factor Xa inhibitor used to reduce the risk of blood clots and stroke in ...
Rybelsus
Rybelsus tablets are used to improve blood sugar control in adults with type 2 diabetes, and may ...
Zepbound
Zepbound (tirzepatide) is an FDA-approved weekly injection for weight loss and obstructive sleep ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.